|
Basic Characteristics of Mutations
|
|
Mutation Site
|
A131C |
|
Mutation Site Sentence
|
When the distribution of the HPV16 E6 and E7 gene variations was compared, the distribution of only A131C (R10R) in the E6 gene showed a different trend between the case and control groups and C749T (S63F) in the E7 gene was significantly different between the case and control groups (P = 0.071 and P = 4.861 x 10-10, respectively). |
|
Mutation Level
|
Nucleotide level |
|
Mutation Type
|
Synonymous substitution |
|
Gene/Protein/Region
|
E6 |
|
Standardized Encoding Gene
|
E6
|
|
Genotype/Subtype
|
HPV16 |
|
Viral Reference
|
HQ644251.1
|
|
Functional Impact and Mechanisms
|
|
Disease
|
Uterine Cervical Neoplasms
|
|
Immune
|
- |
|
Target Gene
|
-
|
|
Clinical and Epidemiological Correlations
|
|
Clinical Information
|
Y |
|
Treatment
|
- |
|
Location
|
China |
|
Literature Information
|
|
PMID
|
30981880
|
|
Title
|
Human papillomavirus type 16 E6 and E7 gene variations associated with cervical cancer in a Han Chinese population
|
|
Author
|
Zhou Z,Yang H,Yang L,Yao Y,Dai S,Shi L,Li C,Yang L,Yan Z,Yao Y
|
|
Journal
|
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
|
|
Journal Info
|
2019 Sep;73:13-20
|
|
Abstract
|
BACKGROUD: Human papillomavirus type 16 (HPV16) is a high-risk HPV subtype and a potent carcinogen. The HPV16 E6 and E7 genes are considered oncogenes that play a core role in the development of cervical cancer. METHODS: In the current study, we enrolled 97 HPV16-positive cervical cancer patients (case group) and 136 HPV16-positive asymptomatic individuals (control group) in a study to analyse the association between HPV16 E6 and E7 gene variations and cervical cancer. RESULTS: Our results showed that three HPV16 sub-lineages (A1-A3, A4 and D3) were present; the distribution of these variants between the case and control group was not significantly different (P = 0.178). When the distribution of the HPV16 E6 and E7 gene variations was compared, the distribution of only A131C (R10R) in the E6 gene showed a different trend between the case and control groups and C749T (S63F) in the E7 gene was significantly different between the case and control groups (P = 0.071 and P = 4.861 x 10-10, respectively). Regarding the sub-lineages, no variations in the E6 gene were significantly different between the case and control group for the A4 (As) and A1-A3 (EUR) sub-lineages. However, the distribution of C749T (S63F) in the E7 gene was significantly different between the case and control groups for the A4 (As) and A1-A3 (EUR) sub-lineages (P = 1.815 x 10-8 and P = 0.008). In the current study, we found that the C749T (S63F) variation in the HPV16 E7 gene was associated with cervical cancer not only in the A4 (As) sub-lineage but also in the A1-A3 (EUR) sub-lineage. CONCLUSION: Our study will provide a good reference for further functional studies of the relationship between cervical cancer carcinogenesis and the HPV16 E6 and E7 genes.
|
|
Sequence Data
|
-
|